Net Sales by Destination, Business and Product type

Net Sales by Destination

Japan11.7%Americas27.9%EMEA31.6%China17.9%Asia-Pacific10.9%
(JPY million)
  2022/3 2023/3 2024/3 2025/3 2026/3
Japan 55,618 59,832 62,184 67,786 58,603
Americas 83,655 105,905 118,782 131,148 139,254
EMEA 94,352 105,200 125,349 140,398 158,034
China 93,373 96,902 109,952 117,970 89,465
Asia-Pacific 36,780 42,661 45,241 51,339 54,649
Total 363,780 410,502 461,510 508,643 500,006
  • ※EMEA: Europe, Middle East, and Africa

Net Sales by Business

Hematology59.9%FCM0.9%Urinalysis8.8%Hemostasis14.5%Immunochemistry4.5%Clinical Chemistry0.6%Life Science5.0%Others5.2%Diagnostics Business99.3%Medical Robotics Business0.7%
(JPY million)
  2022/3 2023/3 2024/3 2025/3 2026/3
Diagnostics Business Hematology 210,367 241,325 274,915 303,202 299,407
FCM 2,074 2,262 3,318 3,638 4,690
Urinalysis 29,978 34,053 39,031 40,838 44,070
Hemostasis 62,087 66,900 72,934 82,346 72,409
Immunochemistry 20,414 23,575 23,646 25,871 22,319
Clinical Chemistry 2,958 3,426 3,378 3,633 2,917
Life Science 17,980 19,937 20,508 21,324 24,960
Others 16,624 16,686 20,030 22,417 25,925
Medical Robotics Business 1,294 2,333 3,745 5,371 3,304
Total 363,780 410,502 461,510 508,643 500,006

Net Sales by Product Type

Instruments20.6%Reagents61.6%Service13.9%Others3.9%
(JPY million)
  2022/3 2023/3 2024/3 2025/3 2026/3
Instruments 86,795 91,796 100,959 104,259 103,232
Reagents 216,167 247,535 280,843 313,818 307,923
Service 46,579 54,350 61,446 68,414 69,275
Others 14,238 16,819 18,261 22,150 19,575
Total 363,780 410,502 461,510 508,643 500,006